Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
Conditions:   Crohn Disease;   Child, Only;   Biologic; Inadequate Intervention:   Drug: Infliximab Sponsor:   Erasmus Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2022 Category: Research Source Type: clinical trials

Prognosis in UC After First Biological
Condition:   Ulcerative Colitis Intervention:   Biological: infliximab, adalimumab, golimumab, vedolizumab, ustekinumab Sponsor:   Tampere University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2022 Category: Research Source Type: clinical trials